By improving insulin sensitivity and reducing inflammation, GLP-1 medications often enhance testosterone and estrogen balance in people with metabolic dysfunction
Obesity medications linked to reduced chance of MS in real world Study suggests potential for repurposing diabetes, weight-loss drugs for MS Written by | The use of obesity medications approved drugs for treating diabetes and promoting weight loss is associated with a reduced chance of developing multiple sclerosis (MS), according to real-world data from the U.S
The details of the plan could still change
They are small, brief and almost constant, and I now realize they are all over my body, not just in my legs
Our medical team will design a tailored protocol to support fat metabolism, body composition, and long-term metabolic health through safe, science-backed care.
This is a very nice and appreciative rundown of all things GSH